FindTrial
Sign In

Study of the effect of a new treatment with antibiotic in babies with brochiolitis.

Using azithromycin to reduce bronchiolitis length of hospital stay in infants.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
REBEC
Registry ID
RBR-257zbc
Enrollment
Unknown
Registered
2012-01-04
Start date
2010-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute viral bronchiolitis

Interventions

Treatment with azythromycin per oral.
drug
D02.540.505.250.050

Sponsors

Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
Lead Sponsor
Fundação de Amparo a Pesquisa do Estado do Rio Grande do Sul
Collaborator

Eligibility

Age
1 Weeks to 12 Months

Inclusion criteria

Inclusion criteria: Infants younger than 12 months, with diagnosis of acute bronchiolitis and hospitalization for at least 24 hours.

Exclusion criteria

Exclusion criteria: Chronic lung disease, cystic fibrosis, congenital heart diseases and previous use of macrolides.

Design outcomes

Primary

MeasureTime frame
Length of hospitalization: number of days of hospitalization, mesuared by date of discharge - date of hospitalization.—

Secondary

MeasureTime frame
Length of need of oxygen therapy: number of days of oxygen use, mesuared by the day when oxygen prescription was cancelled - first day of oxygen prescription.—

Countries

Brazil

Contacts

Public ContactLeonardo;Renato Pinto;Stein

PUCRS;PUCRS

leonardo.pinto@pucrs.br;rstein@pucrs.br51 3320-300, R2313;51-33364211

Outcome results

None listed

Source: REBEC (via WHO ICTRP)